See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Artificial Intelligence
Baseball
Nvidia
Vladimir Putin
Astronauts
Social Media
Airstrike
Stock Markets
Senate
Infrastructure
Property
Published • loading... • Updated

Travere Therapeutics shares plunge as kidney-disease treatment has mixed results in trial

Summary by Ground News
Travere Therapeutics Inc. shares TVTX dropped 37% premarket on Thursday. The company released data from a late-stage study of Filspari in IgA nephropathy. In a head-to-head study versus irbesartan, FilsPari fell short of producing a statistically significant difference by one measure of kidney function.

2 Articles

All
Left
Center
2
Right
BenzingaBenzinga

Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? - Travere Therapeutics (NASDAQ:TVTX)

Travere Therapeutics Inc (NASDAQ: TVTX) announced topline two-year confirmatory secondary endpoint results from its head-to-head Phase 3 PROTECT Study of Filspari (sparsentan) in IgA nephropathy (IgAN) versus Sanofi SA's (NASDAQ: SNY) Avapro (irbesartan).  Filspari demonstrated long-term kidney function preservation and achieved a clinically meaningful difference in estimated glomerular filtration rate (eGFR) total and chronic slope versus irbes…

·New York, United States
Read Full Article
MarketWatchMarketWatch

Travere Therapeutics shares plunge as kidney-disease treatment has mixed results in trial

Travere Therapeutics Inc. shares dropped 37% premarket on Thursday after the company released data from a late-stage study of Filspari in IgA nephropathy, a...

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MarketWatch broke the news in United States on Thursday, September 21, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Disease

Disease

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal